
Transform Ms Cic
Advancing measurement science to enhance clinical research and minimize disease impact globally.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
Total Funding | 000k |
Related Content
Transform MS is a Community Interest Company dedicated to advancing measurement science in the realm of clinical research, with a particular focus on minimizing the impact of Multiple Sclerosis (MS). Operating on a global scale, the company leverages its expertise and collaborative efforts to transform the effectiveness of measurement science. Transform MS serves a diverse clientele, including healthcare professionals, researchers, and MS communities, by providing valuable resources and tools such as Patient Reported Outcome measures like the MSIS 29 and MSWS 12. The business model revolves around licensing these tools and engaging in collaborative projects that support the MS community, particularly in regions like Devon and Cornwall through initiatives like the South West MS Network. Transform MS generates revenue through licensing agreements and partnerships, while also contributing resources to tackle challenges faced by MS services across the UK. The company is actively involved in global initiatives such as MS Brain Health, with key members like Professor Hobart leading significant projects. Transform MS's efforts are aimed at maximizing the value of clinical research and supporting the MS community through strategic collaborations and resource allocation.
Keywords: measurement science, clinical research, Multiple Sclerosis, Patient Reported Outcome, licensing, collaboration, MS community, global initiatives, resource allocation, healthcare professionals.